Androgens in serum and the risk of prostate cancer: a nested case-control study from the Janus serum bank in Norway.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Cancer Epidemiology, Biomarkers and Prevention

• Publication date

  1997-11-01

• Fields of study

  Medicine

• Identifiers
  PMID 9367072
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• 5 alpha-reductase activity and prostate cancer: a case-control study using stored sera.

  1997cited by this paper
• Serum androgens and prostate cancer.

  1996cited by this paper
• Alterations in Circulating Levels of Androgens and PSA During Treatment with Finasteride in Men at High Risk for Prostate Cancer

  1996cited by this paper
• Prospective study of sex hormone levels and risk of prostate cancer.

  1996cited by this paper
• Experiences of the Janus Serum Bank in Norway.

  1995cited by this paper
• Endocrinology of the Prostate

  1993cited by this paper
• Serological precursors of cancer: serum hormones and risk of subsequent prostate cancer.

  1993cited by this paper
• Tissue distribution and ontogeny of steroid 5 alpha-reductase isozyme expression.

  1993cited by this paper
• 5-alpha-reductase activity and risk of prostate cancer among Japanese and US white and black males.

  1992cited by this paper
• Prostate cancer: a current perspective.

  1991cited by this paper
• Clinical and biochemical parameters of androgen action in normal healthy Caucasian versus Chinese subjects.

  1991cited by this paper
• A prospective, population-based study of androstenedione, estrogens, and prostatic cancer.

  1990cited by this paper
• Prediagnostic serum hormones and the risk of prostate cancer.

  1988cited by this paper
• 5 alpha-Reductase activity in the genital skin of hirsute women.

  1985cited by this paper
• 5α-Reductase Activity in the Genital Skin of Hirsute Women*

  1985cited by this paper
• Serum testosterone concentrations in women throughout the menstrual cycle and following HCG administration.

  1974cited by this paper
• Integrated concentration and circadian variation of plasma testosterone in normal men.

  1973cited by this paper

• Application of small interfering RNA technology in cytochrome P450 gene modulation.

  2025cites this paper
• The Role of Serum Testosterone in the Pathogenesis and Treatment of Prostate Cancer: A Review Based on the Clinical Evidence

  2025cites this paper
• Is nerve-sparing radical prostatectomy oncological appropriate for all ISUP 2 cancers?

  2025cites this paper
• Interaction of breast cancer-relevant DNA repair genes and air pollution in relation to breast cancer risk in UK biobank.

  2024cites this paper
• Prostate Safety Events During Testosterone Replacement Therapy in Men With Hypogonadism

  2023cites this paper
• Androgen metabolism in castration-resistant prostate cancer

  2021cites this paper
• Testosterone, testosterone therapy and prostate cancer

  2019cites this paper
• Association between circulating levels of sex steroid hormones and esophageal adenocarcinoma in the FINBAR Study

  2018cites this paper
• NRIP/DCAF6 stabilizes the androgen receptor protein by displacing DDB2 from the CUL4A-DDB1 E3 ligase complex in prostate cancer

  2017cites this paper
• Circulating sex hormones in relation to anthropometric, sociodemographic and behavioural factors in an international dataset of 12,300 men

  2017cites this paper
• Dihydrotestosterone: Biochemistry, Physiology, and Clinical Implications of Elevated Blood Levels

  2017cites this paper
• Endogenous and exogenous testosterone and prostate cancer: decreased-, increased- or null-risk?

  2017influential citation
• Endogenous and exogenous testosterone and the risk of prostate cancer and increased prostate‐specific antigen (PSA) level: a meta‐analysis

  2016cites this paper
• WITHDRAWN: Current opinion in the role of testosterone in the development of prostate cancer: A dynamic model

  2016cites this paper
• Economic evaluation of screening and treatment for prostate cancer in the Midland Cancer Network region in New Zealand

  2016cites this paper
• Current opinion on the role of testosterone in the development of prostate cancer: a dynamic model

  2015cites this paper
• CYP3A5 regulates prostate cancer cell growth by facilitating nuclear translocation of AR

  2015cites this paper
• Type 2 diabetes: a protective factor for prostate cancer? An overview of proposed mechanisms.

  2014cites this paper
• Ethnical disparities of prostate cancer predisposition: genetic polymorphisms in androgen-related genes.

  2013cites this paper
• [Influence of plasmatic testosterone during natural history of prostate cancer: a review].

  2013cites this paper
• Higher sex hormone-binding globulin and lower bioavailable testosterone are related to prostate cancer detection on prostate biopsy

  2013cites this paper
• Androgen glucuronides analysis by liquid chromatography tandem-mass spectrometry: could it raise new perspectives in the diagnostic field of hormone-dependent malignancies?

  2013cites this paper
• Steroid 5-alpha-reductase type 2 (SRD5A2) V89L and A49T polymorphisms and sporadic prostate cancer risk: a meta-analysis

  2013cites this paper
• Androgen receptor GGC polymorphism and testosterone levels associated with high risk of prostate cancer and benign prostatic hyperplasia

  2012cites this paper
• Decision Tree–Based Modeling of Androgen Pathway Genes and Prostate Cancer Risk

  2011cites this paper
• Nukleäre p53-Akkumulation und Marker der genetischen Instabilität beim Prostatakarzinom

  2011cites this paper
• Qu’attendre d’un dosage de la testostéronémie chez un patient ayant un cancer de prostate ?

  2011cites this paper
• Preoperative low serum testosterone levels are associated with tumor aggressiveness in radical prostatectomy treated cancer patients

  2010cites this paper
• Circulating steroid hormones in prostate carcinogenesis. Part 2: Estrogens

  2010cites this paper
• Circulating steroid hormones in prostate carcinogenesis. Part 1 – Androgens

  2010cites this paper
• The Janus Serum Bank - From sample collection to cancer research

  2010cites this paper
• Testosterone therapy and prostate carcinoma

  2009cites this paper
• Testosterone deficiency syndrome: treatment and cancer risk.

  2009cites this paper
• Association between serum sex hormone levels and prostate cancer: effect of prostate cancer on serum testosterone levels.

  2009cites this paper
• Câncer de próstata e testosterona: riscos e controvérsias Prostate carcinoma and testosterone: risks and controversies

  2009cites this paper
• [Prostate carcinoma and testosterone: risks and controversies].

  2009influential citation
• The Janus Serum Bank-From sample collection to cancer research

  2009cites this paper
• Nested Case-Control Study of the Association of Circulating Levels of Serum Insulin-like Growth Factor I and Insulin-like Growth Factor Binding Protein 3 with Breast Cancer in Young Women in Norway

  2008cites this paper
• Androgens and prostate cancer risk.

  2008cites this paper
• The role of testosterone in the pathogenesis of prostate cancer

  2008cites this paper
• Effect of SLCO1B3 Haplotype on Testosterone Transport and Clinical Outcome in Caucasian Patients with Androgen-Independent Prostatic Cancer

  2008cites this paper
• Endogenous sex hormones and prostate cancer: a collaborative analysis of 18 prospective studies.

  2008cites this paper
• A potential paradox in prostate adenocarcinoma progression: oestrogen as the initiating driver.

  2008cites this paper
• Androgen replacement in men undergoing treatment for prostate cancer.

  2008cites this paper
• Estrone sulfate (E1S), a prognosis marker for tumor aggressiveness in prostate cancer (PCa).

  2008cites this paper
• Does testosterone therapy increase the risk of prostate cancer?

  2008cites this paper
• Role of Hormonal and Other Factors in Human Prostate Cancer

  2008cites this paper
• Rôle émergent des oestrogènes dans le cancer de la prostate : sulfate d'oestrone : marqueur de l’agressivité tumorale

  2007cites this paper
• The International Hormone Society

  2007cites this paper
• Endogenous sex hormones and the risk of prostate cancer: A prospective study

  2007cites this paper
• Molecular epidemiology of prostate cancer: hormone-related genetic loci.

  2007cites this paper
• Testosterone, estradiol and aromatase inhibitor therapy in elderly men.

  2007cites this paper
• Sex steroid hormones in young manhood and the risk of subsequent prostate cancer: a longitudinal study in African-Americans and Caucasians (United States)

  2006cites this paper
• The Janus serum bank and biomarkers of cancer

  2006cites this paper
• Heterogeneity in Genetic Susceptibility to Prostate Cancer

  2006influential citation
• Prostate cancer risk in testosterone-treated men.

  2006cites this paper
• Clinical implications of CYP3A polymorphisms

  2006cites this paper
• Transdisciplinary Approaches to Ameliorating Racial Disparities in Prostate Cancer Outcomes

  2006cites this paper
• Changing demography of prostate cancer in Asia.

  2005cites this paper
• History of Diabetes, Clinical Features of Prostate Cancer, and Prostate Cancer Recurrence-Data from CaPSURETM (United States)

  2005cites this paper
• Human prostate cancer risk factors

  2004cites this paper
• Testostérone circulante et cancer de la prostate. Revue de données récentes

  2004cites this paper
• Testosterone and aging : clinical research directions

  2004cites this paper
• The epidemiology of sex steroid hormones and their signaling and metabolic pathways in the etiology of prostate cancer.

  2004cites this paper
• Testosterone replacement therapy. A rush to judgment?

  2004cites this paper
• Nutrition and prostate cancer

  2004cites this paper
• CYP 3 A 4 , CYP 3 A 5 , and CYP 3 A 43 Genotypes and Haplotypes in the Etiology and Severity of Prostate Cancer

  2004cites this paper
• CYP3A4, CYP3A5, and CYP3A43 Genotypes and Haplotypes in the Etiology and Severity of Prostate Cancer

  2004cites this paper
• Masculine vitality: pros and cons of testosterone in treating the andropause.

  2004cites this paper
• High levels of circulating testosterone are not associated with increased prostate cancer risk: A pooled prospective study

  2004cites this paper
• COMMITTEE ON ASSESSING THE NEED FOR CLINICAL TRIALS OF TESTOSTERONE REPLACEMENT THERAPY

  2004cites this paper
• Circulating testosterone and prostate cancer. A brief review

  2004cites this paper
• Hormonal prevention of prostate cancer.

  2003cites this paper
• SRD5A2 gene polymorphisms and the risk of prostate cancer: a meta-analysis.

  2003cites this paper
• Endogenous sex hormones and prostate cancer risk: a case-control study nested within the Carotene and Retinol Efficacy Trial.

  2003cites this paper
• Seminar article Hormonal prevention of prostate cancer

  2003cites this paper
• SRD 5 A 2 Gene Polymorphisms and the Risk of Prostate Cancer : A Meta-Analysis

  2003cites this paper
• Managing the risks of prostate disease during testosterone replacement therapy in older men: recommendations for a standardized monitoring plan.

  2003cites this paper
• Association of the CYP 17 Gene Polymorphism with the Risk of Prostate Cancer : A Meta-Analysis

  2003cites this paper
• Molecular epidemiology of prostate cancer: androgens and polymorphisms in androgen-related genes.

  2003cites this paper
• Association of the CYP17 gene polymorphism with the risk of prostate cancer: a meta-analysis.

  2003cites this paper
• Hormones and prostate cancer: Current perspectives and future directions

  2002cites this paper
• Androgens and Androgen Receptor

  2002cites this paper
• Androgens in Prostate Cancer and Benign Prostatic Hyperplasia

  2002cites this paper
• Mechanisms of the growth inhibitory effects of the isoflavonoid biochanin A on LNCaP cells and xenografts *

  2002cites this paper
• Vasectomy and risk of prostate cancer.

  2002cites this paper
• Prostate Cancer, Androgens, and Estrogens

  2001cites this paper
• Hormones and prostate cancer: what's next?

  2001cites this paper
• Are serum hormones associated with the risk of prostate cancer? Prospective results from the Massachusetts Male Aging Study.

  2001cites this paper
• CHAPTER 24 – Nutrition and Prostate Cancer

  2001cites this paper
• Regulation of the matrix metalloproteinase matrilysin in human prostate carcinoma in vitro

  2001cites this paper
• A role for estrogen receptor β in the regulation of growth of the ventral prostate

  2001cites this paper
• Effect of soymilk consumption on serum estrogen and androgen concentrations in Japanese men.

  2001cites this paper
• Lifestyle determinants of 5alpha-reductase metabolites in older African-American, white, and Asian-American men.

  2001cites this paper
• Smoking and prostate cancer.

  2001cites this paper
• Risk Factors for Prostate Cancer

  2001cites this paper
• Epidemiology of and Risk Factors for Prostate Cancer

  2000cites this paper
• The role of steroid hormones in prostate carcinogenesis.

  2000cites this paper
• Development and Validation of Methods for Detection of Prostate Cancer

  2000cites this paper
• Staging prostate cancer

  2000cites this paper